About GenMe
GenMe is a Technology company based in Gurugram (India) founded in 2023 by Parth Sarthi and Rahul Sumbly. It offers digital financing tools for healthcare businesses including loans and credit. It operates on a B2B model in Technology and Financial Services sectors. Its chief executive, as recorded, is Parth Sarthi. Its Indian entity Genme Technologies Private Limited reported revenue of ₹3.1 Lakh. GenMe offers products and services including Genme Surge, Genme Flow, and Genme Liquid. Its focus areas include FinTech, Insurance Tech, Receivables Financing and Digital Conversion.
Company details
Genme is a fintech company that delivers financial solutions to streamline healthcare supply chains, including working capital loans, supply chain financing, and insurance receivables conversion. It uses AI-powered assessments and digital platforms to empower hospitals, distributors, and suppliers in India. Based in Gurgaon, it focuses on hassle-free funding to enhance business growth and cash flow management.
- Headquarters Gurugram, India
- Founders Parth Sarthi, Rahul Sumbly
- SectorsTechnologyFinancial Services
- Website genme.in
- Social LinkedIn X Instagram
- Legal Name Genme Technologies Private Limited
- Date of Incorporation 26 Jun, 2024
- Jurisdiction Haryana, India
- Annual Revenue₹3.1 Lakh
FY 2025
- Net Loss-₹1.2 Lakh
FY 2025 · -39% margin
- EBITDA-₹1.2 Lakh
FY 2025 · -38% margin
Associated legal entities of GenMe
GenMe is associated with 2 registered companies on The Company Check; the primary company is Genme Technologies Private Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Genme Technologies Private Limited CIN U21001HR2024PTC122873 | Active | 26 Jun 2024 | ₹0.0 Cr | 4 | View details | ||
| Semika Technology Private Limited CIN U72900BR2022PTC060312 | Active | 13 Oct 2022 | Darbhanga, Bihar | 2 | View details |
Products & Services of GenMe
GenMe offers a comprehensive portfolio of products and services, including Genme Surge, Genme Flow, and Genme Liquid.
Empowers healthcare businesses with flexible working capital funding.
Streamlines supply chains through hassle-free credit solutions.
Converts insurance receivables into immediate cash flow.
Board of directors of Genme Technologies Private Limited (GenMe)
Genme Technologies Private Limited is the primary company behind GenMe. The boards of the 2 registered companies of GenMe currently have 5 directors; the longest-serving is Parth Sarthi, appointed in 2022.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Parth Sarthi DIN 09764694 | Director | 13 Oct 2022 | 4 yrs | Semika Technology Private Limited, Genme Technologies Private Limited |
| Rakesh Kumar Ray DIN 09764695 | Director | 13 Oct 2022 | 4 yrs | Semika Technology Private Limited |
| Ashish Kumar DIN 10683889 | Director | 26 Jun 2024 | 2 yrs 3 mo | Genme Technologies Private Limited |
| Krish Vashistha DIN 11213454 | Director | 28 Jul 2025 | 1 yr 2 mo | Genme Technologies Private Limited |
| Saransh Goyal DIN 11218268 | Director | 28 Jul 2025 | 1 yr 2 mo | Genme Technologies Private Limited |
People of GenMe
2 people are tracked at GenMe (2 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder, CEO | Leadership | |
Rahul Sumbly | ex-Co-Founder | Leadership |
Complete people profiles for GenMe
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of GenMe
Figures of Genme Technologies Private Limited, the primary company behind GenMe, for FY 2025. Revenue was ₹3.1 Lakh. Net loss was -₹1.2 Lakh (-39% margin). EBITDA was -₹1.2 Lakh (-38% margin).
- ₹3.1 LakhRevenue · FY 2025
- -₹1.2 LakhNet loss · -39% margin
- -₹1.2 LakhEBITDA · -38% margin
- ₹3.3 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Genme Technologies Private Limited are on its company page.
Detailed financial statements for GenMe
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of GenMe
The website of GenMe (genme.in) receives about 1.3K visits a month.
- Monthly visits1.3K
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about GenMe
GenMe was founded in 2023.
GenMe is headquartered in Gurugram, India. It is registered at Gurugram, Haryana, India.
Parth Sarthi is the CEO of GenMe, as recorded in our data. They have also founded this company.
The primary company behind GenMe, Genme Technologies Private Limited, reported revenue of ₹3.1 Lakh for FY 2025.
Genme is a fintech company that delivers financial solutions to streamline healthcare supply chains, including working capital loans, supply chain financing, and insurance receivables conversion. It uses AI-powered assessments and digital platforms to empower hospitals, distributors, and suppliers in India. Based in Gurgaon, it focuses on hassle-free funding to enhance business growth and cash flow management.
GenMe offers Genme Surge, Genme Flow, and Genme Liquid.
GenMe is associated with 2 legal entities: Genme Technologies Private Limited, Semika Technology Private Limited.
The legal entities of GenMe currently have 5 directors, including Parth Sarthi, Rakesh Kumar Ray, Ashish Kumar and others.